Cytotoxic T lymphocyte perforin and Fas ligand working in concert even when Fas ligand lytic action is still not detectable

Immunology

Volumn 133, Issue 2, 2011, Pages 190-196

  Hassin, David ^a   Garber, Orit G ^b   Meiraz, Avihai ^b   Schiffenbauer, Yael S ^c   Berke, Gideon ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c Cell Kinetics   (Israel)

Author keywords

Allotransplantation; Apoptosis; CD8 cytotoxic T cells; Granzymes perforin

Indexed keywords

CASPASE 8; FAS LIGAND; PERFORIN; PROTEIN BID;

ANIMAL CELL; ARTICLE; CELL KILLING; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REACTION TIME;

ANIMALS; BLOTTING, WESTERN; CYTOTOXINS; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERFORIN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 79954991695     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2011.03426.x     Document Type: Article

References (40)

1. 2+-independent T cell-mediated cytotoxicity. J Exp Med 1993; 177:195-200.
2. Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S, Hengartner H, Golstein P. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994; 265:528-30.
3. + T cells accounts for two distinct types of effector cytotoxic T lymphocytes in vivo. Immunology 2009; 128:69-82.
4. Cullen SP, Martin SJ. Mechanisms of granule-dependent killing. Cell Death Differ 2008; 15:251-62.
5. Pardo J, Wallich R, Martin P et al. Granzyme B-induced cell death exerted by ex vivo CTL: discriminating requirements for cell death and some of its signs. Cell Death Differ 2008; 15:567-79.
6. Aartman IH, Eijkman MA, Makkes PC. [Treatment of anxious patients in special dental care centers. From local initiatives to organized dentistry]. Ned Tijdschr Tandheelkd 1998; 105:365-7.
7. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 1995; 14:5579-88.
8. Kang TB, Oh GS, Scandella E, Bolinger B, Ludewig B, Kovalenko A, Wallach D. Mutation of a self-processing site in caspase-8 compromises its apoptotic but not its nonapoptotic functions in bacterial artificial chromosome-transgenic mice. J Immunol 2008; 181:2522-32.
9. Strasser A, Jost PJ, Nagata S. The many roles of FAS receptor signaling in the immune system. Immunity 2009; 30:180-92.
10. + T cells during primary activation. Int Immunol 2002; 14:605-13.
11. + cytotoxic T lymphocytes and natural killer cells: participation of Fas ligand in granule exocytosis model of cytotoxicity. Biochem Biophys Res Commun 2002; 296:328-36.
12. Stinchcombe JC, Griffiths GM. Secretory mechanisms in cell-mediated cytotoxicity. Annu Rev Cell Dev Biol 2007; 23:495-517.
13. He JS, Ostergaard HL. CTLs contain and use intracellular stores of FasL distinct from cytolytic granules. J Immunol 2007; 179:2339-48.
14. + T cells in influenza virus-infected mice. Proc Natl Acad Sci U S A 2003; 100:2657-62.
15. Zagury D, Bernard J, Thierness N, Feldman M, Berke G. Isolation and characterization of individual functionally reactive cytotoxic T lymphocytes: conjugation, killing and recycling at the single cell level. Eur J Immunol 1975; 5:818-22.
16. Sanderson CJ. Morphological aspects of lymphocyte mediated cytotoxicity. Adv Exp Med Biol 1982; 146:3-21.
17. Lowin B, Mattman C, Hahne M, Tschopp J. Comparison of Fas(Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes. Int Immunol 1996; 8:57-63.
18. + T cell cytotoxic activity during adoptive T cell therapy in mice. J Clin Invest 2008; 118:1390-7.
19. de Vries JF, von dem Borne PA, van Luxemburg-Heijs SA, Heemskerk MH, Willemze R, Falkenburg JH, Barge RM. Differential activation of the death receptor pathway in human target cells induced by cytotoxic T lymphocytes showing different kinetics of killing. Haematologica 2007; 92:1671-8.
20. Walsh CM, Glass AA, Chiu V, Clark WR. The role of the Fas lytic pathway in a perforin-less CTL hybridoma. J Immunol 1994; 153:2506-14.
21. Berke G. Killer Lymphocytes. Berlin: Springer, 2007.
22. Berke G, Rosen D. Highly lytic in vivo primed cytolytic T lymphocytes devoid of lytic granules and BLT-esterase activity acquire these constituents in the presence of T cell growth factors upon blast transformation in vitro. J Immunol 1988; 141:1429-36.
23. Berke G, Gabison D. Energy requirements of the binding and lytic steps of T lymphocyte-mediated cytolysis of leukemic cells in vitro. Eur J Immunol 1975; 5:671-5.
24. Schiffenbauer YS, Kalma Y, Trubniykov E, Gal-Garber O, Weisz L, Halamish A, Sister M, Berke G. A cell chip for sequential imaging of individual non-adherent live cells reveals transients and oscillations. Lab Chip 2009; 9:2965-72.
25. Berke G, Gabison D, Feldman M. The frequency of effector cells in populations containing cytotoxic T lymphocytes. Eur J Immunol 1975; 5:813-8.
26. O'Reilly LA, Divisekera U, Newton K et al. Modifications and intracellular trafficking of FADD/MORT1 and caspase-8 after stimulation of T lymphocytes. Cell Death Differ 2004; 11:724-36.
27. Wang K, Yin XM, Chao DT, Milliman CL, Korsmeyer SJ. BID: a novel BH3 domain-only death agonist. Genes Dev 1996; 10:2859-69.
28. Sarig R, Zaltsman Y, Marcellus RC, Flavell R, Mak TW, Gross A. BID-D59A is a potent inducer of apoptosis in primary embryonic fibroblasts. J Biol Chem 2003; 278:10707-15.
29. Kawasaki A, Shinkai Y, Kuwana Y et al. Perforin, a pore-forming protein detectable by monoclonal antibodies, is a functional marker for killer cells. Int Immunol 1990; 2:677-84.
30. Stulting RD, Berke G. Nature of lymphocyte-tumor interaction. A general method for cellular immunoabsorption. J Exp Med 1973; 137:932-42.
31. Li JH, Rosen D, Ronen D, Behrens CK, Krammer PH, Clark WR, Berke G. The regulation of CD95 ligand expression and function in CTL. J Immunol 1998; 161:3943-9.
32. Voskoboinik I, Smyth MJ, Trapani JA. Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol 2006; 6:940-52.
33. Bossi G, Griffiths GM. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat Med 1999; 5:90-6.
34. Peixoto A, Evaristo C, Munitic I, Monteiro M, Charbit A, Rocha B, Veiga-Fernandes H. CD8 single-cell gene coexpression reveals three different effector types present at distinct phases of the immune response. J Exp Med 2007; 204:1193-205.
35. Rosenberg SA, Dudley ME. Adoptive cell therapy for the treatment of patients with metastatic melanoma. Curr Opin Immunol 2009; 21:233-40.
36. + tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis. J Immunol 2001; 167:5042-51.
37. Afonina IS, Cullen SP, Martin SJ. Cytotoxic and non-cytotoxic roles of the CTL/NK protease granzyme B. Immunol Rev 2010; 235:105-16.
38. Adrain C, Murphy BM, Martin SJ. Molecular ordering of the caspase activation cascade initiated by the cytotoxic T lymphocyte/natural killer (CTL/NK) protease granzyme B. J Biol Chem 2005; 280:4663-73.
39. Pinkoski MJ, Waterhouse NJ, Heibein JA et al. Granzyme B-mediated apoptosis proceeds predominantly through a Bcl-2-inhibitable mitochondrial pathway. J Biol Chem 2001; 276:12060-7.
40. Metkar SS, Wang B, Ebbs ML, Kim JH, Lee YJ, Raja SM, Froelich CJ. Granzyme B activates procaspase-3 which signals a mitochondrial amplification loop for maximal apoptosis. J Cell Biol 2003; 160:875-85.